Exact Mass: 573.0873

Exact Mass Matches: 573.0873

Found 22 metabolites which its exact mass value is equals to given mass value 573.0873, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

GDP-3,6-dideoxy-D-galactose

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2S,3R,5R,6R)-3,5-dihydroxy-6-methyl-tetrahydropyran-2-yl] hydrogen phosphate

C16H25N5O14P2 (573.0873)

dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose

[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrosooxan-2-yl] hydrogen phosphate

C18H29N3O14P2 (573.1125)

Cmp-kdn

CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate; CMP-3-deoxy-D-glycero-beta-D-galacto-non-2-ulosonate; CMP-KDN

C18H28N3O16P (573.1207)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite Thymectacin (NB1011) is an agent selectively targeting tumor cells that have a high expression of thymidylate synthase (TS). Thymectacin is an aryloxy phosphoramidate derivative of BVdU (brivudin)[1][2].

Uridylyl-2-5-phospho-adenosine

C19H24N7O12P (573.1221)

Phosphoribulosylformimino-AICAR-P

C15H21N5O15P2-4 (573.0509)

dTDP-N-hydroxy-beta-L-evernosamine(2-)

C18H29N3O14P2-2 (573.1125)

PhosphoribosylformiminoAICAR-phosphate

C15H21N5O15P2-4 (573.0509)

dTDP-4-formamido-4,6-dideoxy-alpha-D-glucose

C17H25N3O15P2-2 (573.0761)

dTDP-2,3,6-trideoxy-3-C-methyl-3-nitro-beta-L-arabino-hexopyranose

C17H25N3O15P2-2 (573.0761)

1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide tetraanion

C15H21N5O15P2-4 (573.0509)

opacaline C

C19H18BrF6N5O4 (573.0446)

A natural product found in Pseudodistoma opacum.

6-phospho-beta-D-MurNAc-(1->4)-D-GlcNAc(3-)

C19H30N2O16P-3 (573.1333)

[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrosooxan-2-yl] hydrogen phosphate

C18H29N3O14P2 (573.1125)

5-[(5-phospho-1-deoxy-D-ribulos-1-ylimino)methylamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide(4-)

C15H21N5O15P2 (573.0509)

An organophosphate oxoanion that is the tetraanionic form of 5-[(5-phospho-1-deoxy-D-ribulos-1-ylimino)methylamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide.

1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide(4-)

C15H21N5O15P2 (573.0509)

An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of 1-(5-phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide.

CMP-3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid

C18H28N3O16P (573.1207)

A CMP-sugar having 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid as the sugar component.

methyl (2s)-2,3-dihydroxy-3-[(1s,17s,20z,24r,26r)-4,11,24-trihydroxy-10-methoxy-6,13-dioxo-25-oxa-16-azahexacyclo[15.7.2.0¹,²⁶.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]hexacosa-2,4,7(12),8,10,14,20-heptaen-18,22-diyn-26-yl]butanoate

methyl (2s)-2,3-dihydroxy-3-[(1s,17s,20z,24r,26r)-4,11,24-trihydroxy-10-methoxy-6,13-dioxo-25-oxa-16-azahexacyclo[15.7.2.0¹,²⁶.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]hexacosa-2,4,7(12),8,10,14,20-heptaen-18,22-diyn-26-yl]butanoate

C30H23NO11 (573.1271)